Delivery Order 75N93025D00011-75N93026F00001

The National Institute of Allergy and Infectious Diseases issued a $75,000 delivery order to Eurofins Discovery Services North America, LLC on July 16, 2019, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ for non-GLP off-the-shelf standard initial profiling of lead compounds in rodent pharmacokinetics screening assays. The order has a ceiling value of $112,500 and an ultimate completion date of July 17, 2020. Place of performance is St. Charles, MO....

The National Institute of Allergy and Infectious Diseases awarded a $6.17M firm fixed-price delivery order to Eurofins Discovery Services North America, LLC for preclinical models of infectious diseases. The delivery order, issued on December 9, 2021, is scheduled for completion by November 30, 2026, and will be performed at the contractor's facility in St. Peters, Missouri. This award falls under the "Nonclinical Services for Development of Interventional Agents" master IDIQ vehicle...

This delivery order, awarded May 1, 2018, provides nonclinical services for the development of interventional agents targeting infectious diseases through the National Institute of Allergy and Infectious Diseases (NIAID). Eurofins Discovery Services North America, LLC, a foreign-owned contract research organization headquartered in St. Charles, Missouri, was awarded this firm-fixed-price delivery order with a ceiling value of $1.21 million and an ultimate completion date of April 30, 2025. The...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Eurofins Discovery Services North America, LLC on June 10, 2020, under the Nonclinical Services for Development of Interventional Agents parent master IDIQ. The order value is $18,273.00 and addresses non-GMP synthesis of galidesivir mono-, di-, and triphosphate (BCX6870) in support of coronavirus COVID-19 research. Place of performance is St. Charles, Missouri. The order is firm fixed price with an ultimate...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on April 1, 2020, with a ceiling value of $8.95 million for nonclinical services supporting the development of interventional agents for infectious diseases. The order is issued under the Nonclinical Services for Development of Interventional Agents parent IDIQ. Work is performed in Menlo Park, CA, with an ultimate completion date of March 31, 2021. The contract is priced on a...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a Delivery Order contract to Eurofins Panlabs, Inc. on August 14, 2018. The $506,922.00 Firm Fixed Price contract is for lead optimization screening assays to evaluate absorption, distribution, metabolism, excretion (ADME), safety, and pharmacokinetic (PK) properties. This Delivery Order falls under the parent Nonclinical Services for Development...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 19, 2011, with a ceiling value of $10.4 million for preclinical services supporting the development of interventional agents for infectious diseases. The order covers lead identification, development, chemistry, and synthesis services under a Cost Plus Fixed Fee pricing structure. Place of performance is Menlo Park, CA. The ultimate completion date is August 14, 2018. No...

The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on September 13, 2011, with a ceiling value of $4,399,991.97 for preclinical services in the development of interventional agents for infectious diseases. The order encompasses administrative, technical, and management support activities. Place of performance is Menlo Park, CA. The ultimate completion date is February 15, 2020. Pricing is cost plus fixed fee with no set-aside applied.

The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on September 6, 2017, with a ceiling value of $110,115.92 under the Preclinical Services for Biopharmaceutical Product Development IDIQ. Place of performance is Rockville, MD. The order was initially set to run through February 10, 2018 and was extended to April 13, 2018 at no additional cost. Pricing is cost plus fixed fee. No set-aside was used for this order.

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Task Order E06 "Custom Screening Assays for Metabolic Stability and Peptidase Selectivity" to Eurofins Panlabs, Inc. for $359,026.82 on a firm fixed price basis. This task order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery/indefinite quantity (IDIQ) contract. Eurofins Panlabs, Inc. is a contract...